Registration, but no funding application for biomarker use of Keytruda

+Print Archive
News

Registration, but no funding application for biomarker use of Keytruda

Chris Jackson
Cancer Society medical director Chris Jackson says bespoke biologics are expensive drugs
Cancer Society medical director Chris Jackson welcomes the immunology drug pembrolizumab being registered this month for use in patients with specific